These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 16675853)

  • 1. C. elegans as a model for Friedreich Ataxia.
    Ventura N; Rea SL; Handerson ST; Condò I; Testi R; Johnson TE
    FASEB J; 2006 May; 20(7):1029-30. PubMed ID: 16675853
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired respiration is positively correlated with decreased life span in Caenorhabditis elegans models of Friedreich Ataxia.
    Zarse K; Schulz TJ; Birringer M; Ristow M
    FASEB J; 2007 Apr; 21(4):1271-5. PubMed ID: 17215485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy induction extends lifespan and reduces lipid content in response to frataxin silencing in C. elegans.
    Schiavi A; Torgovnick A; Kell A; Megalou E; Castelein N; Guccini I; Marzocchella L; Gelino S; Hansen M; Malisan F; Condò I; Bei R; Rea SL; Braeckman BP; Tavernarakis N; Testi R; Ventura N
    Exp Gerontol; 2013 Feb; 48(2):191-201. PubMed ID: 23247094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of Caenorhabditis elegans frataxin increases sensitivity to oxidative stress, reduces lifespan, and causes lethality in a mitochondrial complex II mutant.
    Vázquez-Manrique RP; González-Cabo P; Ros S; Aziz H; Baylis HA; Palau F
    FASEB J; 2006 Jan; 20(1):172-4. PubMed ID: 16293572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causative role of oxidative stress in a Drosophila model of Friedreich ataxia.
    Llorens JV; Navarro JA; Martínez-Sebastián MJ; Baylies MK; Schneuwly S; Botella JA; Moltó MD
    FASEB J; 2007 Feb; 21(2):333-44. PubMed ID: 17167074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of frataxin extends the lifespan of Caenorhabditis elegans.
    Ventura N; Rea S; Henderson ST; Condo I; Johnson TE; Testi R
    Aging Cell; 2005 Apr; 4(2):109-12. PubMed ID: 15771615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the gene in Friedreich ataxia.
    Hebert MD
    Biochimie; 2008 Aug; 90(8):1131-9. PubMed ID: 18206656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron dysregulation in Friedreich ataxia.
    Wilson RB
    Semin Pediatr Neurol; 2006 Sep; 13(3):166-75. PubMed ID: 17101455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lived C. elegans mitochondrial mutants as a model for human mitochondrial-associated diseases.
    Ventura N; Rea SL; Testi R
    Exp Gerontol; 2006 Oct; 41(10):974-91. PubMed ID: 16945497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and protease dysfunction in the yeast model of Friedreich ataxia.
    Bulteau AL; Dancis A; Gareil M; Montagne JJ; Camadro JM; Lesuisse E
    Free Radic Biol Med; 2007 May; 42(10):1561-70. PubMed ID: 17448903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia.
    Auchère F; Santos R; Planamente S; Lesuisse E; Camadro JM
    Hum Mol Genet; 2008 Sep; 17(18):2790-802. PubMed ID: 18562474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia.
    Sarsero JP; Li L; Wardan H; Sitte K; Williamson R; Ioannou PA
    J Gene Med; 2003 Jan; 5(1):72-81. PubMed ID: 12516053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low predisposition to instability of the Friedreich ataxia gene in Cuban population.
    Mariño TC; Zaldivar YG; Mesa JM; Mederos LA; Rodríguez RA; Gotay DA; Labrada RR; Ochoa NC; Macleod P; Pérez LV
    Clin Genet; 2010 Jun; 77(6):598-600. PubMed ID: 20569261
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of interruptions in the GAA trinucleotide repeat expansion in the FXN gene of Friedreich ataxia.
    Holloway TP; Rowley SM; Delatycki MB; Sarsero JP
    Biotechniques; 2011 Mar; 50(3):182-6. PubMed ID: 21486239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frataxin, a molecule of mystery: trading stability for function in its iron-binding site.
    Lane DJ; Richardson DR
    Biochem J; 2010 Feb; 426(2):e1-3. PubMed ID: 20141512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncommon features in Cuban families affected with Friedreich ataxia.
    Cruz-Mariño T; González-Zaldivar Y; Laffita-Mesa JM; Almaguer-Mederos L; Aguilera-Rodríguez R; Almaguer-Gotay D; Rodríguez-Labrada R; Canales-Ochoa N; Macleod P; Velázquez-Pérez L
    Neurosci Lett; 2010 Mar; 472(2):85-9. PubMed ID: 20109528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A polymorphic miR-155 binding site in AGTR1 is associated with cardiac hypertrophy in Friedreich ataxia.
    Kelly M; Bagnall RD; Peverill RE; Donelan L; Corben L; Delatycki MB; Semsarian C
    J Mol Cell Cardiol; 2011 Nov; 51(5):848-54. PubMed ID: 21771600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of Friedreich ataxia.
    Pandolfo M
    Mov Disord; 2001 Sep; 16(5):815-21. PubMed ID: 11746610
    [No Abstract]   [Full Text] [Related]  

  • 19. Frataxin shows developmentally regulated tissue-specific expression in the mouse embryo.
    Jiralerspong S; Liu Y; Montermini L; Stifani S; Pandolfo M
    Neurobiol Dis; 1997; 4(2):103-13. PubMed ID: 9331900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frataxin interacts with Isu1 through a conserved tryptophan in its beta-sheet.
    Leidgens S; De Smet S; Foury F
    Hum Mol Genet; 2010 Jan; 19(2):276-86. PubMed ID: 19884169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.